drugset
drugset / Trial / NCT02986594

Diagnosis and Treatment Strategy of Recurrent Spontaneous Abortion Associated With Thrombophilla

NCT02986594 ↗

Phase 4 Unknown 600 enrolled Shanghai First Maternity and Infant Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

In this clinical cohort study, the investigators observe the efficacy of low molecular weight heparin in the treatment of thrombophilia with recurrent pregnancy loss with a prospective randomized controlled trial.

Timeline

Start
2016-11
Primary completion
2019-10
Completion
2019-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 75 mg —
Subject Aspirin Small molecule 100 mg —
Subject Heparin Other / unclassified 4100 iu —

Indications

thrombophilia